Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00216151
Recruitment Status : Terminated (Study terminated due to low patient enrollment.)
First Posted : September 22, 2005
Last Update Posted : May 2, 2011
Novartis Pharmaceuticals
Walther Cancer Institute
Information provided by:
Hoosier Cancer Research Network

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : March 2007